AK-778-XXMU

N/A

Report date: 2022/01/13 17:57:37
NME

Base Information

Drug NameAK-778-XXMU
Drug Alias NameAK-778-XXMU
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA synthesis inhibitors
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXinxiang Medical University
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A